Aspire Biopharma Holdings (ASBP) Tax Provisions (2024)
Aspire Biopharma Holdings' (ASBP) quarterly Tax Provisions came in at $1013.0 in Q3 2024.
Powered by 
Analysis
Aspire Biopharma Holdings (ASBP) Tax Provisions (2024) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Tax Provisions for 1 consecutive years, with $1013.0 the latest figure, recorded in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 393.00 Mn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 242.00 Mn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 292.00 Mn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 230.90 Mn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 15.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | -59.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 34.90 Mn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | -3.96 Mn |
| 10 | Aspire Biopharma Holdings | 64.13 Mn | 51.96 Mn | -30,086.00 | - |